Description
| Product Name | CAT.No | Size |
| HTLV 1+2 ELISA | BXE910A | 96T |
Product Description
The Biorex Diagnostics HTLV 1+2 ELISA kit is a highly sensitive and specific microplate enzyme-linked immunosorbent assay (ELISA) designed for the qualitative detection of antibodies to Human T-cell Lymphotropic Viruses types 1 and 2 (HTLV-1/2) in human serum or plasma. HTLV 1+2 are retroviruses that can be transmitted through blood transfusions, sexual contact, and vertical transmission from mother to child, typically via breastfeeding. While infection can remain asymptomatic for many years, HTLV-1 is strongly associated with serious conditions such as Adult T-cell Leukemia/Lymphoma (ATLL) and HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). HTLV-2, although less frequently linked to malignancy, is associated with certain neurological complications and immunological disorders. Early and accurate detection of antibodies is critical for patient management, prevention of disease transmission, and epidemiological surveillance, particularly in endemic regions and blood donation centres.
Key Features
- Qualitative Microplate ELISA – provides reliable detection of HTLV 1+2 antibodies.
- High Sensitivity and Specificity – ensures precise and trustworthy results for clinical use.
- Serum and Plasma Compatibility – suitable for routine testing in clinical laboratories and blood banks.
- Reproducible Performance – delivers consistent results across multiple assay runs and operators.
- Comprehensive Kit Components – includes ready-to-use reagents, controls, and standards for streamlined workflow.
- Versatile Application – ideal for blood donor screening, diagnostic testing, research, and epidemiological studies.
The Biorex Diagnostics HTLV 1+2 ELISA kit offers a trusted, efficient, and clinically relevant solution for laboratories and healthcare providers. By enabling accurate detection of these antibodies, the assay supports timely diagnosis and management of infected individuals, reduces the risk of transfusion-related infections, and contributes to improved public health outcomes. Its robust design, reproducibility, and user-friendly workflow make it suitable for routine laboratory testing, blood screening programmes, and research applications. The kit provides dependable results that help guide clinical decision-making, enhance patient safety, and support comprehensive surveillance efforts, ensuring both individual and population-level benefits.
Contact Us for more information.